AJP - Heart  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (October 31, 2008). doi:10.1152/ajpheart.00687.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/1/H140    most recent
00687.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohan, I. K
Right arrow Articles by Kuppusamy, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohan, I. K
Right arrow Articles by Kuppusamy, P.
Submitted on July 2, 2008
Revised on October 12, 2008
Accepted on October 28, 2008

Cardioprotection by HO-4038, a Novel Verapamil Derivative, Targeted against Ischemia and Reperfusion-mediated Acute Myocardial Infarction

Iyyapu K Mohan, Mahmood Khan1, Sheik Wisel2, Karuppaiyah Selvendiran1, Arun Sridhar, Cynthia A Carnes3, Balazs Bognar, Tamas Kalai, Kalman Hideg, and Periannan Kuppusamy2*

1 DHLRI
2 The Ohio State University
3 Ohio State University

* To whom correspondence should be addressed. E-mail: kuppusamy.1{at}osu.edu.

Many cardiac interventional procedures, such as coronary angioplasty, stenting, and thrombolysis, attempt to reintroduce blood-flow (reperfusion) to an ischemic region of myocardium. However, the reperfusion is accompanied by a complex cascade of cellular and molecular events resulting in oxidative damage, termed myocardial ischemia-reperfusion (I-R) injury. In this study, we evaluated the ability of HO-4038, an N-hydroxypiperidine derivative of verapamil, on the modulation of myocardial tissue oxygenation (pO2), I-R injury, and key signaling molecules involved in cardioprotection in an in vivo rat model of acute myocardial infarction (MI). MI was created in rats by ligating the left anterior descending coronary artery (LAD) for 30 min followed by 24-h reperfusion. Verapamil or HO-4038 was infused through jugular vein 10 min before the induction of ischemia. Myocardial pO2 and free-radical scavenging ability of HO-4038 were measured using EPR spectroscopy. HO-4038 showed a significantly better scavenging ability of reactive-oxygen radicals when compared to verapamil. The cardiac contractile functions in the I-R hearts were significantly higher recovery in HO-4038 group compared to verapamil group. A significant decrease in the plasma levels of creatine kinase (CK) and lactate dehydrogenase (LDH) was observed in HO-4038 group compared to verapamil or untreated I-R groups. The left-ventricular infarct size was significantly less in HO-4038 group (23±2%) compared to untreated I-R group (36±4%). HO-4038 significantly attenuated the hyperoxygenation (36±1 mmHg) during reperfusion compared to untreated I-R group (44±2 mmHg). HO-4038-treated group also markedly attenuated superoxide production, increased nitric oxide generation, and enhanced Akt and Bcl-2 levels in the reperfused myocardium. Overall, the results demonstrated that HO-4038 significantly protected hearts against I-R-induced cardiac dysfunction and damage through combined beneficial actions of calcium-channel blocking, antioxidant, and pro-survival signaling activities.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Wisel, M. Khan, M. L. Kuppusamy, I. K. Mohan, S. M. Chacko, B. K. Rivera, B. C. Sun, K. Hideg, and P. Kuppusamy
Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 543 - 550.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.